Evidence map›Paper›PMID 40188042›Full record

ArticleBMC bioinformatics2025

Goistrat: gene-of-interest-based sample stratification for the evaluation of functional differences.

Carlos Uziel Pérez Malla, Jessica Kalla, Andreas Tiefenbacher, Gabriel Wasinger, Kilian Kluge, Gerda Egger, Raheleh Sheibani-Tezerji

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos Uziel Pérez MallaDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Jessica KallaDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Andreas TiefenbacherDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Gabriel WasingerDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Kilian KlugeDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Gerda EggerDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria.
Raheleh Sheibani-TezerjiDepartment of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1090, Austria. raheleh.sheibani-tezerji@meduniwien.ac.at.

Funding

Austrian Science Fund P32771
6 · The paper itself

Abstract

purposeUnderstanding the impact of gene expression in pathological processes, such as carcinogenesis, is crucial for understanding the biology of cancer and advancing personalised medicine. Yet, current methods lack biologically-informed-omics approaches to stratify cancer patients effectively, limiting our ability to dissect the underlying molecular mechanisms.

resultsTo address this gap, we present a novel workflow for the stratification and further analysis of multi-omics samples with matched RNA-Seq data that relies on MSigDB curated gene sets, graph machine learning and ensemble clustering. We compared the performance of our workflow in the top 8 TCGA datasets and showed its clear superiority in separating samples for the study of biological differences. We also applied our workflow to analyse nearly a thousand prostate cancer samples, focusing on the varying expression of the FOLH1 gene, and identified specific pathways such as the PI3K-AKT-mTOR gene sets as well as signatures linked to prostate tumour aggressiveness.

conclusionOur comprehensive approach provides a novel tool to identify disease-relevant functions of genes of interest (GOI) in large datasets. This integrated approach offers a valuable framework for understanding the role of the expression variation of a GOI in complex diseases and for informing on targeted therapeutic strategies.

Indexed as

Computational BiologyNeoplasmsProstatic NeoplasmsSoftwareDatabases, GeneticGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMachine LearningMaleFOLH1Gene of interestGSEAGSVANode2VecProstate cancerPSMA

Identifiers

PMID40188042
PMCPMC11971790

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.